期刊文献+

依托泊苷长循环热敏前体脂质体的制备工艺研究

Preparedtion Technology of Etoposide Long-Circulating Thermo-Sensitive Proliposomes
下载PDF
导出
摘要 目的:对依托泊苷(Etoposide,VP-16)长循环热敏前体脂质体的制备工艺进行研究,并对该制备工艺进行方法学及制剂质量考察。方法:应用薄膜分散法制成VP-16长循环热敏脂质体,进一步借助冷冻干燥技术进行依托泊苷长循环热敏前体脂质体的制备;采用zeta电势测定仪及HPLC等技术进行方法学考察,主要包括脂质体的包封率、粒径、载药量、电位、释放度、稳定性。结果:VP-16长循环热敏前体脂质体水合形成长循环热敏脂质体,粒径为(105.2±3.4)nm,Zeta电位为(-11.9±1.7)m V,包封率可达96.8%;该脂质体在相变温度42℃下药物释放达到96%以上。结论:VP-16长循环热敏前体脂质体的制备工艺稳定,脂质体载药量大,包封率高;药物含量及包封率的测定方法简单、快速而准确,因而,该研究可为VP-16开发成静脉注射用新制剂提供数据支持。 Objective: Study on the preparation technology of Etoposide(VP-16) long-circulating thermo-sensitive proliposomes and investigate its methodology. Methods: Film dispersion method was used to prepare VP-16 long-circulating thermo-sensitive liposomes which were further prepared as VP-16 long-circulating proliposomes by vacuum freeze-drying technique. The shape and size distribution of proliposomes were detected by transmission electron Zetasizer, and the content of VP-16 was determined by HPLC.The encapsulation efficiency(EE) and the release rate of liposome were computed as well. Results: The VP-16 long-circulating thermo-sensitive liposomes aquated as the Etoposide long-circulating proliposomes, the appearance of liposomes was whole round, distribution uniform, the mean particle size were(105.2±3.4) nm, and zeta potential were(-11.9±1.7) m V. The liposome 42 ℃ temperature under the drug release above 96%. Conclusion:The preparation technology of Etoposide long-circulating thermo-sensitive proliposomes was stable, drug loading and entrapping capacity of liposomes were well. The methods for determination of Etoposide content and entrapment efficiency were simple, rapid and accurate. These studies can provide bases for further developing VP-16 as thermo-sensitive liposomes intravenous injection.
出处 《黑龙江医药》 CAS 2015年第2期275-277,共3页 Heilongjiang Medicine journal
关键词 依托泊苷 前体脂质体 长循环热敏脂质体 Etoposide long-circulating thermosensitive liposomes proliposomes
  • 相关文献

参考文献6

  • 1Strieth S, Eichhom ME, Werner A, et al. Paclitaxel encapsulated in cationic liposomes increases tumor mierovessel leakiness and improves therapeutic efficacy in combination with Cisplatin [J]. Clin Cancer Res, 2008, 15(14):4603-4611.
  • 2Dhanikula RS, Dhanikula AB, Panchagnula R. Thermoreversible liposomal poloxamer gel for the delivery ofpaclitaxel: dose pro- portionality and hematological toxicity studies [J]. Pharmazie, 2008, 63(6): 439-445.
  • 3Yang T, Choi MK, Cui FD,et al. Antitumor effect of paclitax- el-loaded PEGylated immunoliposomes against human breast cancer cells [J]. Pharm Res, 2007, 24(12): 2402-2411.
  • 4Shimose S, Sugita T, Nitta Y, et al. Effect of thermo-sansitive li- posomal doxorubicin with hyperthermia on primary tumor and lung metastases in hamster osteosareoma [J]. lnt J Oncol, 2001, 19(3): 585-589.
  • 5de Smet M, Langereis S, van den Bosch S, et al. Tempera- / ture-sensitive liposomes for doxorubicin delivery under MRI guidance [J]. J Control Release, 2010, 143(1): 120-127.
  • 6Ponce AM, Vujaskovic Z, Yuan F, et al. Hyperthermia mediated liposomal drug deliver [J]. Int J Hyperthermia, 2006, 22(3): 205 -213.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部